Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07530913

Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients

Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients: Randomized Controlled Trials

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled study aims to evaluate the effectiveness of a digital rehabilitation exercise platform in patients undergoing living donor liver transplantation. A total of 36 adult patients who require ongoing rehabilitation after living donor liver transplantation will be recruited and randomly assigned in a 1:1 ratio to either an intervention group or a control group. The intervention group will receive a personalized exercise program delivered through a digital rehabilitation platform in addition to standard exercise education, whereas the control group will receive standard exercise education only. Physical function, body composition, quality of life, and physical activity will be assessed before surgery, at discharge, at 1 month after discharge, and at 3 months after discharge to determine whether the digital rehabilitation platform improves recovery-related outcomes during the post-transplant period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDigital Rehabilitation PlatformA personalized digital rehabilitation exercise program for patients undergoing living donor liver transplantation. The program includes exercise guidance during hospitalization and continued home-based self-exercise and self-management after discharge through a digital rehabilitation platform.
BEHAVIORALStandard Exercise EducationUsual rehabilitation exercise education provided during hospitalization for patients undergoing living donor liver transplantation, with instructions for continued self-exercise and self-management after discharge.

Timeline

Start date
2026-03-26
Primary completion
2026-08-31
Completion
2026-12-31
First posted
2026-04-15
Last updated
2026-04-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07530913. Inclusion in this directory is not an endorsement.